![Quiver Logo](/static/img/logo-icon.png)
![QNCX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/qncx.png)
Quince Therapeutics, Inc. Common Stock
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view QNCX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of QNCX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by QNCX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to QNCX
Recent picks made for QNCX stock on CNBC
ETFs with the largest estimated holdings in QNCX
Flights by private jets registered to QNCX
![Quiver Logo](/static/img/logo-icon.png)